טיגציל

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

TIGECYCLINE

Saatavilla:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

ATC-koodi:

J01AA12

Lääkemuoto:

אבקה להכנת תמיסה לאינפוזיה

Koostumus:

TIGECYCLINE 50 MG/DOSE

Antoreitti:

תוך-ורידי

Prescription tyyppi:

מרשם נדרש

Valmistaja:

PFIZER INC, USA

Terapeuttinen ryhmä:

TIGECYCLINE

Terapeuttinen alue:

TIGECYCLINE

Käyttöaiheet:

TYGACIL is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:Complicated Skin and Skin Structure Infections:Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates ), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis .Complicated Intra-abdominal Infections:Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosu

Valtuutus päivämäärä:

2022-02-28